Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What is QT interval prolongation?

David A Vorchheimer1

  • 1Mount Sinai School of Medicine, Coronary Care Unit, Mount Sinai Medical Center, New York, NY USA.

The Journal of Family Practice
|June 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2026 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (Revision of the 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology): A report of the ACC Competency Management Committee.

Heart rhythm·2026
Same author

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR advanced training statement on advanced cardiovascular imaging: A Report of the ACC Competency Management Committee.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2025
Same author

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.

Journal of cardiovascular computed tomography·2025
Same author

Exploring the Changes in Code Status During the COVID-19 Pandemic and the Implications for Future Pandemic Care.

The American journal of hospice & palliative care·2022
Same author

Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2016
Same author

Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin.

Thrombosis and haemostasis·2014
Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023
Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023
Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023
Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023
Same journal

Renewing the dream.

The Journal of family practice·2023
Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023
See all related articles

QT interval prolongation, a heart electrical irregularity, increases ventricular arrhythmia risk. Identifying at-risk patients is crucial for preventing serious complications from drug-induced QT prolongation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • QT interval prolongation is a cardiac electrical abnormality.
  • It is associated with an increased risk of potentially fatal ventricular arrhythmias.
  • Drug-induced QT prolongation is a significant concern in clinical practice.

Purpose of the Study:

  • To review the risks associated with QT interval prolongation.
  • To discuss the identification of patients at risk for serious complications.
  • To emphasize preventative strategies for drug-induced QT interval prolongation.

Main Methods:

  • Literature review of studies on QT interval prolongation.
  • Analysis of risk factors and patient populations.
  • Discussion of clinical implications and management strategies.

Related Experiment Videos

Main Results:

  • Serious complications of drug-induced QT interval prolongation are infrequent.
  • Certain patient populations and factors increase the risk.
  • Early identification of at-risk individuals is key.

Conclusions:

  • While rare, serious complications of QT interval prolongation can occur.
  • Risk stratification and patient monitoring are essential.
  • Preventing these events relies on identifying and managing at-risk patients.